Taiwan FDA registration d05d769d80f2641e83981b0f0220a651
Abbott second-generation aspartate transaminase assay set
TW: 亞培第二代天門冬氨酸轉胺酶檢驗試劑組
Taiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Sep 30, 2022 – Sep 30, 2027ActiveRegistration details
- Analysis ID
- d05d769d80f2641e83981b0f0220a651
- Customs Code
- DHA05603585909
Company information
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used to quantify aspartate aminotransferase (AST) in human serum or plasma on the Alinity c System.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1100 天門冬胺酸轉胺酶試驗系統
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Sep 30, 2022
- Expiry Date
- Sep 30, 2027
About this record
Access comprehensive regulatory information for Abbott second-generation aspartate transaminase assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d05d769d80f2641e83981b0f0220a651 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices